TCTMD

TCTMD provides news articles related to interventional cardiology. The site has a bias towards the pharmaceutical industry and presents information in a way that favors their products. There are conflicts of interest with some of its sources and the study cited in one article had significant differences between patients who received TAVI and those who received medical management, but this information is not disclosed on the website.

72%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on its reporting.

Bias

80%

Examples:

  • The articles provided are biased towards the pharmaceutical industry and present information in a way that favors their products. The site also has conflicts of interest with some of its sources.

Conflicts of Interest

60%

Examples:

  • The site has conflicts of interest with some of its sources. The study that was cited in the article about low-risk TAVI found that there were significant differences between patients who received TAVI and those who received medical management. However, this information is not disclosed on the website.

Contradictions

75%

Examples:

  • There is no clear evidence to support the claims made about the safety and efficacy of ticagrelor in preventing major bleeding after PCI for ACS patients. The study found that there was no significant difference in major adverse cardiovascular and cerebrovascular events between patients who continued DAPT for 12 months or those who discontinued aspirin and continued ticagrelor for one month.

Deceptions

70%

Examples:

  • The site presents information in a way that favors the pharmaceutical industry and their products. The study cited in the article about low-risk TAVI found significant differences between patients who received TAVI and those who received medical management. However, this information is not disclosed on the website.

Recent Articles

  • New Study Finds Aspirin Reduces Bleeding Complications After PCI for Heart Attack Patients

    New Study Finds Aspirin Reduces Bleeding Complications After PCI for Heart Attack Patients

    Broke On: Tuesday, 09 April 2024 A new study published in The Lancet found that stopping aspirin one month after percutaneous coronary intervention (PCI) for an acute coronary syndrome significantly reduces bleeding complications in heart attack patients. This is the first time a placebo-controlled trial has confirmed this finding, and it was presented at the American College of Cardiology 2024 Scientific Sessions on Sunday, April 7th.

  • Recent Studies Highlight Effectiveness and Potential Risks of TAVR in Treating Aortic Stenosis

    Broke On: Sunday, 01 October 2023 Recent studies have shown that Transcatheter Aortic Valve Replacement (TAVR) is effective in treating aortic stenosis in low-risk patients. The PARTNER 3 and Evolut trials found that TAVR outperformed surgical aortic valve replacement (SAVR) in terms of mortality, stroke, and rehospitalization rates at one year. A separate study found that adding left atrial appendage occlusion (LAAO) to TAVR did not increase the risk of complications.